title: Cardiovascular research is thriving in China.
abstract: Cardiovascular disease has become the leading cause of death and constitutes a serious public health issue in China. Faced with the burgeoning epidemic of cardiovascular disease and the huge burden and economic losses it causes, the Chinese government has attached the utmost importance to cardiovascular research, increasing funding to support basic and clinical studies, integrating resources and recruiting outstanding talent from overseas. The continued and growing support from the government has yielded substantial changes in terms of new discoveries, scientific publications and drug research and development within the last decade. In spite of the advances in cardiovascular research, China still faces significant challenges ahead in encouraging innovation, developing the prevention-oriented health policies and strengthening international collaboration.
authors: Department of Physiology, The Fourth Military Medical University, Xi'an, China.
authors: F
authors: F
authors: Gao
authors: Department of Health Sciences, National Natural Science Foundation of China, Beijing, China.
authors: R J
authors: RJ
authors: Sun
authors: Atherosclerosis Research Center, Nanjing Medical University, Nanjing, China.
authors: Y
authors: Y
authors: Ji
authors: Department of Pharmacology, Harbin Medical University, Harbin, China.
authors: B F
authors: BF
authors: Yang
mesh_terms: D035843:Biomedical Research; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002681:China; D055808:Drug Discovery; D006801:Humans
chemical_list: D002317:Cardiovascular Agents